Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy

AI BRIEFING

• ⬤ Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy
• ⬤ Agreement enables selection of Kahimmune’s first companion neoantigen therapy candidate against colorectal and pancreatic cancer
• ⬤ Financial support from an undisclosed partner to accelerate development of the therapy